Vascular imaging market will near $6 billion by 2022

By Romily Broad
Share
New research suggests that the global market for vascular imaging technlogies will accelerate 6.5% per year over the next five years, up to USD$5.95bill...

New research suggests that the global market for vascular imaging technlogies will accelerate 6.5% per year over the next five years, up to USD$5.95 billion by 2022.

The research from MarketsAndMarkets identifies the primary drivers as improving technlogies, aging populations, and the increasing prevelance of cardiovascular diseases (CVDs). It says North America will represent the largest market share geographically, featuring as it does both an aging population susceptible to high rates of CVD and the greatest dispursment of investment in new technlogies.

Of the technologies driving most growth, magnetic resonance imaging will dominate the market in 2017, continuing to be the preferred choice due to its non-invasiveness and high efficacy. 

Coronary angiography will dominate the cardiovascular procedure segment of the market, primarily driven by the ever increasing geriatric population of the world.

The projection sees a overall value uplift of over 25% on a market worth $4.35 billion today.

Share

Featured Articles

NTT & Olympus: World's First Cloud Endoscopy System

NTT and medical technology company Olympus put on a demonstration, showing the IOWN APN's low-latency capability, for the first cloud endoscopy system

Richter BioLogics' New Biopharmaceutical GMP Facility

Richter BioLogics GmbH & Co KG's a new biopharmaceutical GMP facility in Germany will boost production capabilities and local employment

GE HealthCare's Pilot Study Shows Value of Portrait Mobile

A pilot study from GE Healthcare has shown the value of Portrait Mobile Continuous Monitoring Solution, a leap in post-surgical monitoring efficiency

50% of Teens to be Affected by Myopia Globally by 2050

Telehealth & COVID-19

NVIDIA’s AI Insights for Diabetes Prevention with GluFormer

Technology & AI

Novo Nordisk's CagriSema Next Gen Weight-Loss Treatment

Medical Devices & Pharma